Radiation dosimetry of para-chloro-2-[18F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging

Isabella Silins,Adrian Moreno,Anders Wall,Franklin Aigbirhio,Mark Gurnell,Morris Brown,Sara Roslin,Gunnar Antoni,Per Hellman,Anders Sundin,Mark Lubberink
DOI: https://doi.org/10.1186/s13550-024-01109-2
IF: 3.434
2024-05-22
EJNMMI Research
Abstract:[ 11 C]metomidate, a methyl ester analogue of etomidate, is used for positron emission tomography of adrenocortical cancer, and has been tested in recent clinical trials for lateralization in primary aldosteronism (PA). However, in PA, visualization as well as uptake quantification are hampered by the tracer's rather high non-specific liver uptake, and its overall clinical usefulness is also limited by the short 20-minute half-life of carbon-11. Therefore, we evaluated para-chloro-2-[ 18 F]fluoroethyl-etomidate, [ 18 F]CETO, a fluorine-18 (T 1/2 =109.8 min) analogue, as a potential new adrenocortical PET tracer. The aim of this study was to assess radiation dosimetry of [ 18 F]CETO.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?